✦ LIBER ✦

Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer

✍ Scribed by Karen E. Hoffman; Ming-Hui Chen; Brian J. Moran; Michelle H. Braccioforte; Daniel Dosoretz; Sharon Salenius; Michael J. Katin; Rudi Ross; Anthony V. D'Amico

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 166 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24974

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prostate-specific antigen recurrence and

Prostate-specific antigen recurrence and mortality after conventional dose radiation therapy in select men with low-risk prostate cancer

✍ Joshua H. Petit; Ming-Hui Chen; Marian Loffredo; Brenda Sussman; Andrew A. Rensh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Cancer-specific mortality after radiatio

Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer

✍ Henry K. Tsai; Ming-Hui Chen; David G. McLeod; Peter R. Carroll; Jerome P. Richi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancer‐specific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with short‐course androgen suppression therapy (RT+AST) or radica

Comorbidity and competing risks for mort

Comorbidity and competing risks for mortality in men with prostate cancer

✍ Timothy J. Daskivich; Karim Chamie; Lorna Kwan; Jessica Labo; Atreya Dash; Sheld 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

Prostate cancer-specific mortality after

Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors

✍ Anthony V. D'Amico; Ming-Hui Chen; William J. Catalona; Leon Sun; Kimberly A. Ro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

## Abstract ## BACKGROUND. Estimates of prostate cancer‐specific mortality (PCSM) were determined after radical prostatectomy (RP) or radiation therapy (RT) in men with ≥1 high‐risk factors. ## METHODS. The study cohort comprised 948 men who underwent RP (N = 660) or RT (N = 288) for localized p

Pretreatment prostate-specific antigen v

Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy

✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a

Substantial family history of prostate c

Substantial family history of prostate cancer in black men recruited for prostate cancer screening : Results from the Prostate Cancer Risk Assessment Program

✍ Kathleen Mastalski; Elliot J. Coups; Karen Ruth; Susan Raysor; Veda N. Giri 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB